BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 4, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 22, 2011
View Archived Issues
Roche discovers novel class of inhibitors of the hexosamine biosynthesis pathway
Read More
U.K. study describes distribution of transient receptor potential TRPA1 channel in human lung
Read More
Novel engineered physiocrine has thrombopoietic effects in vivo
Read More
Large-scale phase III trial assesses ChimeriVax-Dengue vaccine in Singapore
Read More
Valeant Pharmaceuticals reports phase III data on efinaconazole
Read More
Promising results emerge from first phase III tedizolid trial in ABSSSI
Read More
Antisense therapy enters phase I trial in children with spinal muscular atrophy
Read More
Ardea Biosciences initiates phase III lesinurad program
Read More
Trimel Pharmaceuticals announces completion of phase II TBS-2 trial in anorgasmia
Read More
Hanmi and Kinex sign Orascovery licensing agreement
Read More
Xarelto obtains E.U. approval in two new indications
Read More
Enrollment complete in first phase III migalastat hydrochloride trial
Read More
Lundbeck reports on MAA for Selincro
Read More
AbGenomics to regain rights to immunotherapeutic for psoriasis and other immunological diseases
Read More
NewGen Therapeutics acquires targeted oncology programs
Read More
Phase I trials evaluate candidate prime-boost malaria vaccine regimen in healthy adults and children
Read More
Canadian university prepares new prostanoid EP4 receptor agonists
Read More
Novel epidermal growth factor receptor inhibitors synthesized by Chinese university
Read More
New lysophospholipid S1P1 receptor ligands patented by the Institute of Materia Medica
Read More
Hande Starlake Bioscience prepares new PARP inhibitors
Read More
Boehringer Ingelheim discloses new chemokine CCR2 receptor antagonists
Read More
FDA approves fixed-dose combination tablet for treatment of hypertension
Read More
FDA accepts tofacitinib NDA for review
Read More
Orexo reports novel pharmacokinetic findings for breakthrough cancer pain treatment
Read More
BioDelivery Sciences reports on confirmatory BEMA-buprenorphine/naloxone trial
Read More
Novartis stops phase III aliskiren hemifumarate trial
Read More
Takeda to expand oncology pipeline with acquisition of Intellikine
Read More